Bulletin
Investor Alert

The Wall Street Journal Archives | Email alerts

March 8, 2021, 5:08 p.m. EST

Russian disinformation has a new target: vaccines made by Pfizer and other Western companies

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    BioNTech SE ADR (BNTX)
  • X
    BioNTech SE ADR (22UA)

or Cancel Already have a watchlist? Log In

Michael R. Gordon, and Dustin Volz

WASHINGTON — Russian intelligence agencies have mounted a campaign to undermine confidence in Pfizer Inc.’s and other Western vaccines, using online publications that in recent months have questioned the vaccines’ development and safety, U.S. officials said.

An official with the State Department’s Global Engagement Center, which monitors foreign disinformation efforts, identified four publications that he said have served as fronts for Russian intelligence.

The websites played up the vaccines’ risk of side effects, questioned their efficacy, and said the U.S. had rushed the Pfizer PFE vaccine, developed with German partner BioNTech /zigman2/quotes/214419716/composite BNTX +7.69% /zigman2/quotes/222361179/delayed XE:22UA +10.44% , through the approval process, among other false or misleading claims.

Don’t miss: Vaccine diplomacy: Putin seeks to leverage Sputnik V to build Russia’s global influence

Though the outlets’ readership is small, U.S. officials say they inject false narratives that can be amplified by other Russian and international media.

An expanded version of this report appears at WSJ.com.

Trending at WSJ.com:

Russia mounts campaign to combat skepticism of its Sputnik V vaccine

COVID pill showing early promise in testing

/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 151.54
+10.82 +7.69%
Volume: 4.62M
April 16, 2021 4:00p
P/E Ratio
1,446
Dividend Yield
N/A
Market Cap
$33.99 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/222361179/delayed
XE : Germany: Xetra
124.80
+11.80 +10.44%
Volume: 330,919
April 16, 2021 6:30p
P/E Ratio
5,244
Dividend Yield
N/A
Market Cap
€28.39 billion
Rev. per Employee
€248,493
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.